Furthermore, in matched pairs, the activity of breast-cancer-related pathways (e.g., PTEN, Tp53, BRCA1, Her2, and Cyclin D1) in the PDTXs was correlated with and predicted the activity scores in the originating breast cancer samples (Figure S1D). The gene discussed is ERBB2; the disease is breast carcinoma.